<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>imatinib</title><link>http://www.unboundmedicine.com/medline/ebm/research/imatinib</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Extragastrointestinal Stromal Tumors of the Omentum: Review Apropos of a Case with a Novel Gain-of-Function KIT Mutation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19894031/full_citation/Extragastrointestinal_Stromal_Tumors_of_the_Omentum:_Review_Apropos_of_a_Case_with_a_Novel_Gain_of_Function_KIT_Mutation_</link><description>Dedemadi G, Georgoulis G, Kontopanos D, et al. <br/><span class="title">Extragastrointestinal Stromal Tumors of the Omentum: Review Apropos of a Case with a Novel Gain-of-Function KIT Mutation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of gastrointestinal cancer">J Gastrointest Cancer 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19894031/abstract/Extragastrointestinal_Stromal_Tumors_of_the_Omentum:_Review_Apropos_of_a_Case_with_a_Novel_Gain_of_Function_KIT_Mutation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19894031/full_citation/Extragastrointestinal_Stromal_Tumors_of_the_Omentum:_Review_Apropos_of_a_Case_with_a_Novel_Gain_of_Function_KIT_Mutation_">Full Citation</a></description></item><item><title>Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890907/full_citation/Cytoreductive_therapy_in_108_adults_with_systemic_mastocytosis:_Outcome_analysis_and_response_prediction_during_treatment_with_interferon_alpha_hydroxyurea_imatinib_mesylate_or_2_chlorodeoxyadenosine_</link><description>Lim KH, Pardanani A, Butterfield JH, et al. <br/><span class="title">Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of hematology">Am J Hematol 2009 Oct 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890907/abstract/Cytoreductive_therapy_in_108_adults_with_systemic_mastocytosis:_Outcome_analysis_and_response_prediction_during_treatment_with_interferon_alpha_hydroxyurea_imatinib_mesylate_or_2_chlorodeoxyadenosine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890907/full_citation/Cytoreductive_therapy_in_108_adults_with_systemic_mastocytosis:_Outcome_analysis_and_response_prediction_during_treatment_with_interferon_alpha_hydroxyurea_imatinib_mesylate_or_2_chlorodeoxyadenosine_">Full Citation</a></description></item><item><title>Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890786/full_citation/Allogeneic_Stem_Cell_Transplantation_for_Pediatric_and_Adolescent_Patients_with_CML:_Results_from_the_Prospective_Trial_CML_paed_I_</link><description>Suttorp M, Claviez A, Bader P, et al. <br/><span class="title">Allogeneic Stem Cell Transplantation for Pediatric and Adolescent Patients with CML: Results from the Prospective Trial CML-paed I. [JOURNAL ARTICLE]</span><br/><span class="source" title="Klinische Padiatrie">Klin Padiatr 2009 Nov; 221(6):351-357.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890786/abstract/Allogeneic_Stem_Cell_Transplantation_for_Pediatric_and_Adolescent_Patients_with_CML:_Results_from_the_Prospective_Trial_CML_paed_I_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890786/full_citation/Allogeneic_Stem_Cell_Transplantation_for_Pediatric_and_Adolescent_Patients_with_CML:_Results_from_the_Prospective_Trial_CML_paed_I_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890786/Allogeneic_Stem_Cell_Transplantation_for_Pediatric_and_Adolescent_Patients_with_CML:_Results_from_the_Prospective_Trial_CML_paed_I_">Find Related Articles</a> </description></item><item><title>A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890374/full_citation/A_comprehensive_target_selectivity_survey_of_the_BCR_ABL_kinase_inhibitor_INNO_406_by_kinase_profiling_and_chemical_proteomics_in_chronic_myeloid_leukemia_cells_</link><description>Rix U, Remsing Rix LL, Terker AS, et al. <br/><span class="title">A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K">Leukemia 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890374/abstract/A_comprehensive_target_selectivity_survey_of_the_BCR_ABL_kinase_inhibitor_INNO_406_by_kinase_profiling_and_chemical_proteomics_in_chronic_myeloid_leukemia_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890374/full_citation/A_comprehensive_target_selectivity_survey_of_the_BCR_ABL_kinase_inhibitor_INNO_406_by_kinase_profiling_and_chemical_proteomics_in_chronic_myeloid_leukemia_cells_">Full Citation</a></description></item><item><title>Dysregulation of bone remodelling by imatinib mesylate.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890095/full_citation/Dysregulation_of_bone_remodelling_by_imatinib_mesylate_</link><description>Vandyke K, Fitter S, Dewar AL, et al. <br/><span class="title">Dysregulation of bone remodelling by imatinib mesylate. [JOURNAL ARTICLE]</span><br/><span class="source" title="Blood">Blood 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890095/abstract/Dysregulation_of_bone_remodelling_by_imatinib_mesylate_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890095/full_citation/Dysregulation_of_bone_remodelling_by_imatinib_mesylate_">Full Citation</a> | <a href="http://www.bloodjournal.org/cgi/pmidlookup%3fview=long%26amp;pmid=19890095">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890095/Dysregulation_of_bone_remodelling_by_imatinib_mesylate_">Find Related Articles</a> </description></item><item><title>Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886867/full_citation/Potential_utility_of_small_tyrosine_kinase_inhibitors_in_the_treatment_of_diabetes_</link><description>Mokhtari D, Welsh N <br/><span class="title">Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes. [Journal Article]</span><br/><span class="source" title="Clinical science (London, England : 1979)">Clin Sci (Lond) 2010 Feb; 118(4):241-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886867/abstract/Potential_utility_of_small_tyrosine_kinase_inhibitors_in_the_treatment_of_diabetes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886867/full_citation/Potential_utility_of_small_tyrosine_kinase_inhibitors_in_the_treatment_of_diabetes_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19886867/Potential_utility_of_small_tyrosine_kinase_inhibitors_in_the_treatment_of_diabetes_">Find Related Articles</a> </description></item><item><title>The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886798/full_citation/The_Effect_of_Imatinib_on_Cytomegalovirus_Reactivation_in_Hematopoietic_Cell_Transplantation_</link><description>Travi G, Pergam SA, Xie H, et al. <br/><span class="title">The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886798/abstract/The_Effect_of_Imatinib_on_Cytomegalovirus_Reactivation_in_Hematopoietic_Cell_Transplantation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886798/full_citation/The_Effect_of_Imatinib_on_Cytomegalovirus_Reactivation_in_Hematopoietic_Cell_Transplantation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19886798/The_Effect_of_Imatinib_on_Cytomegalovirus_Reactivation_in_Hematopoietic_Cell_Transplantation_">Find Related Articles</a> </description></item><item><title>Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885836/full_citation/Rare_incidence_of_congestive_heart_failure_in_gastrointestinal_stromal_tumor_and_other_sarcoma_patients_receiving_imatinib_mesylate_</link><description>Trent JC, Patel SS, Zhang J, et al. <br/><span class="title">Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885836/abstract/Rare_incidence_of_congestive_heart_failure_in_gastrointestinal_stromal_tumor_and_other_sarcoma_patients_receiving_imatinib_mesylate_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885836/full_citation/Rare_incidence_of_congestive_heart_failure_in_gastrointestinal_stromal_tumor_and_other_sarcoma_patients_receiving_imatinib_mesylate_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.24683">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19885836/Rare_incidence_of_congestive_heart_failure_in_gastrointestinal_stromal_tumor_and_other_sarcoma_patients_receiving_imatinib_mesylate_">Find Related Articles</a> </description></item><item><title>Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885746/full_citation/Dasatinib_induced_complete_molecular_response_after_allogeneic_hematopoietic_stem_cell_transplantation_in_Philadelphia_chromosome_positive_acute_lymphoblastic_leukemia_resistant_to_prior_imatinib_containing_regimen:_a_case_report_and_discussion_</link><description>Czyz A, Lewandowski K, Kroll R, et al. <br/><span class="title">Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medical oncology (Northwood, London, England)">Med Oncol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885746/abstract/Dasatinib_induced_complete_molecular_response_after_allogeneic_hematopoietic_stem_cell_transplantation_in_Philadelphia_chromosome_positive_acute_lymphoblastic_leukemia_resistant_to_prior_imatinib_containing_regimen:_a_case_report_and_discussion_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885746/full_citation/Dasatinib_induced_complete_molecular_response_after_allogeneic_hematopoietic_stem_cell_transplantation_in_Philadelphia_chromosome_positive_acute_lymphoblastic_leukemia_resistant_to_prior_imatinib_containing_regimen:_a_case_report_and_discussion_">Full Citation</a></description></item><item><title>Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884523/full_citation/Chronic_Myeloid_Leukemia:_An_Update_of_Concepts_and_Management_Recommendations_of_European_LeukemiaNet_</link><description>Baccarani M, Cortes J, Pane F, et al. <br/><span class="title">Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884523/abstract/Chronic_Myeloid_Leukemia:_An_Update_of_Concepts_and_Management_Recommendations_of_European_LeukemiaNet_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884523/full_citation/Chronic_Myeloid_Leukemia:_An_Update_of_Concepts_and_Management_Recommendations_of_European_LeukemiaNet_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19884523">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884523/Chronic_Myeloid_Leukemia:_An_Update_of_Concepts_and_Management_Recommendations_of_European_LeukemiaNet_">Find Related Articles</a> </description></item></channel></rss>